Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Prepaid Assets (2023 - 2025)

Connect Biopharma Holdings' Prepaid Assets history spans 3 years, with the latest figure at $7.8 million for Q3 2025.

  • For Q3 2025, Prepaid Assets changed N/A year-over-year to $7.8 million; the TTM value through Sep 2025 reached $7.8 million, changed N/A, while the annual FY2024 figure was $2.5 million, 6.3% up from the prior year.
  • Prepaid Assets for Q3 2025 was $7.8 million at Connect Biopharma Holdings, up from $3.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.8 million in Q3 2025 and bottomed at $2.3 million in Q4 2023.
  • The 3-year median for Prepaid Assets is $3.1 million (2024), against an average of $4.1 million.
  • The largest YoY upside for Prepaid Assets was 6.3% in 2024 against a maximum downside of 6.3% in 2024.
  • A 3-year view of Prepaid Assets shows it stood at $2.3 million in 2023, then rose by 6.3% to $2.5 million in 2024, then surged by 216.52% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for CNTB's Prepaid Assets are $7.8 million (Q3 2025), $3.8 million (Q1 2025), and $2.5 million (Q4 2024).